Skip to main content
Premium Trial:

Request an Annual Quote

Precipio Issues $1.9M in Shares to Cancel Debt

NEW YORK (GenomeWeb) – Precipio announced late on Tuesday it issued more than 1.8 million shares of its common stock in order to cancel debt totaling $1.9 million.

In a document filed with the US Securities and Exchange Commission, the company said that it issued the shares on Feb. 12 to several of its trade creditors to settle the debt. Precipio did not identify the creditors.

Separately, the company said in an SEC document last week that it had reached a deal with Leviston Resources to sell it, from time to time, shares of Precipio's common stock having an aggregate offering price of up to $8 million.

Last week, the company also announced preliminary fourth quarter revenues of $945,000, a 200 percent increase year over year from the year-ago period.

The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.